Brief: Cynata Therapeutics Posts HY Revenue And Other Income Of A$1.8 Million
28/02/2023 07:40
Feb 28 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* HY REVENUE AND OTHER INCOME A$1.8 MILLION VERSUS A$7.0
MILLION
* HY LOSS FROM ORDINARY ACTIVITIES AFTER TAX ATTRIBUTABLE
A$5.2
MILLION VERSUS LOSS A$1.1 MILLION
Source text for Eikon: ID:nASX2l3Q2Z
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million